| Literature DB >> 32089073 |
Dae Hyun Lee1, Merna Armanious1, Jessica Huang1, Daniel Jeong2, Mihaela Druta3, Michael G Fradley1.
Abstract
Entities:
Keywords: Pembrolizumab; cardio-oncology; cardiotoxicity; immune checkpoint inhibitor; myocarditis
Year: 2020 PMID: 32089073 DOI: 10.1177/1078155220904152
Source DB: PubMed Journal: J Oncol Pharm Pract ISSN: 1078-1552 Impact factor: 1.809